文献速递腹部技术与安全MR

磁共振弹性成像:实用问题,来自AJR纤维化影像学特别系列

MR Elastography: Practical Questions, From the AJR Special Series on Imaging of Fibrosis.
PubMed 文献 · AJR Am J Roentgenol · 2023-05-10

本文综述磁共振弹性成像(MRE)的临床应用,讨论其作为无创检测和分期肝纤维化工具的价值;大多数头对头比较研究认为MRE在肝纤维化分期中诊断性能最高;MRE测量有望作为疾病严重程度的定量替代指标和临床结局预测因子,并正被纳入临床指南。

要点

  • MRE在肝纤维化分期中的诊断性能在头对头比较研究中通常最高。
  • MRE肝硬度是检测高危NASH(NASH伴分期≥F2纤维化)的最重要单一生物标志物。
  • MRI测量的肝脂肪升高是检测非酒精性脂肪性肝炎(NASH)的最重要单一生物标志物。

核心结论

  • MRE已成为无创检测和分期已知或疑似慢性肝病患者肝纤维化的重要工具。
  • 大多数头对头比较研究得出结论:MRE在肝纤维化分期中的诊断性能高于其他实验室和影像学检查。
  • 基于MRE的测量有望作为疾病严重程度的定量替代指标和重要临床结局的预测因子。
  • MRE在慢性肝病管理中的适当作用正被积极纳入公认的临床指南。

研究设计与样本

  • 综述:聚焦MRE临床使用的一系列实用问题,未报告系统检索范围与纳入文献数量。
  • MRE于1995年首次描述,2009年获FDA批准。

诊断标准与关键数值

  • MRE肝硬度是检测高危NASH(即NASH伴分期≥F2纤维化)的最重要单一生物标志物。
  • MRI测量的肝脂肪升高是检测NASH的最重要单一生物标志物。

临床应用与阅片要点

  • 原文未据此给出具体阅片或报告操作推荐。

局限性

  • 肝纤维化分期金标准活检的准确性局限正日益被认识到。
  • MRE技术进展有望提供更高精度和新生物标志物,从而可能独立评估炎症及其他组织学过程。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

MR elastography (MRE), first described in 1995 and FDA-cleared in 2009, has emerged as an important tool for noninvasively detecting and staging liver fibrosis in patients with known or suspected chronic liver disease. This review focuses on a series of practical questions about the clinical use of MRE. Most head-to-head comparison studies with other laboratory and imaging-based tests have concluded that MRE has the highest diagnostic performance among tests for staging liver fibrosis. Limitations in the accuracy of biopsy as a standard of truth in staging liver fibrosis are increasingly being recognized. MRE-based measurements show promise as quantitative surrogates of disease severity and predictors of important clinical outcomes. The appropriate role of MRE in the management of patients with chronic liver disease is being actively incorporated into recognized clinical guidelines. Growing evidence shows that MRI measurement of elevated liver fat is the most important single biomarker for detecting nonalcoholic steatohepatitis (NASH) and that MRE-based liver stiffness is the most important single biomarker for detecting at-risk NASH (i.e., NASH with stage ≥ F2 fibrosis). Advances in MRE technology are offering higher precision and new biomarkers, which have potential to allow independent assessment of inflammation and other histologic processes in addition to fibrosis.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Yin, Ehman. MR Elastography: Practical Questions, From the AJR Special Series on Imaging of Fibrosis. AJR Am J Roentgenol. 2023. PMID: 37162036. doi:10.2214/AJR.23.29437

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。